SEC Form 4 · accession 0001171843-18-000689
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sylvia Cheung
Officer — Chief Financial Officer
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $61.47 | Jan 24, 2018 | A | 21,400 | A | — | Jan 24, 2028 | Common Stock | 21,400 | 21,400 | D |
Explanation of responses
- F1The stock options vest in four equal annual installments beginning January 24, 2019.